Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX2 | Q96LB1 | 6/20 | 0.74 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.69 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.67 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.67 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.67 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.67 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.67 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.60 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Morphine 3-Glucuronide SCHEMBL614298 | 1.00 | MRGPRX2 (0.74) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| SCHEMBL3017103 | 0.92 | MRGPRX2 (0.89) | MRGPRX2OPRM1OPRD1OPRK1 | |
| SCHEMBL2171816 | 0.92 | MRGPRX2 (0.89) | MRGPRX2OPRM1OPRD1OPRK1 | |
| SCHEMBL1032567 | 0.89 | OPRD1 (0.71) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| Morphine 3-Glucuronide SCHEMBL8409700 | 0.86 | OPRM1 (0.62) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| Morphine 3-Glucuronide SCHEMBL8412630 | 0.86 | OPRM1 (0.62) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| SCHEMBL6753388 | 0.85 | MRGPRX2 (1.00) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| SCHEMBL8409352 | 0.85 | MRGPRX2 (1.00) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| SCHEMBL1261490 | 0.85 | MRGPRX2 (1.00) | MRGPRX2OPRM1OPRD1OPRK1ADRB1 | |
| Morphine SCHEMBL9219855 | 0.84 | OPRM1 (0.75) | MRGPRX2OPRM1OPRD1OPRK1SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4142753-A1 | IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING CANCER FIBROBLASTS | Figene, LLC (US) | 2023-03-08 | — | — | EP | claimed |
| EP-4114419-A1 | FIBROBLAST AND TLR ACTIVATED FIBROBLAST TREATMENT OF VIRAL INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME | Figene, LLC (US) | 2023-01-11 | — | — | EP | claimed |
| EP-4045064-A1 | TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS | Figene, LLC (US) | 2022-08-24 | — | — | EP | claimed |
| US-20220090037-A1 | COMPOSITIONS OF BETA-GLUCURONIDASE ENZYME BLENDS WITH ENHANCED ENZYMATIC ACTIVITY AND METHODS OF PREPARATION THEREOF | INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. | 2022-03-24 | — | — | US | claimed |
| WO-2022047486-A2 | DENTAL AND PERIODONTAL APPLICATION OF FIBROBLASTS | FIGENE, LLC (US) | 2022-03-03 | — | — | WO | claimed |
| US-20200040319-A1 | COMPOSITIONS OF ENZYMES BLENDS AND METHODS OF PREPARATION THEREOF | INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. | 2020-02-06 | — | — | US | claimed |
| CN-107964030-A | A kind of synthetic method of morphine derivatives and application | 宜昌人福药业有限责任公司 | 2018-04-27 | — | — | CN | claimed |
| EP-2118634-A2 | DRUG DETECTION KIT AND METHOD | Nathaniel, Andrew Homer (ZA) | 2009-11-18 | — | — | EP | claimed |
| US-20080254550-A1 | DRUG DETECTION KIT AND METHOD | NATHANIEL ANDREW HOMER | 2008-10-16 | — | — | US | claimed |
| WO-2008096225-A2 | DRUG DETECTION KIT AND METHOD | NATHANIEL ANDREW HOMER (ZA) | 2008-08-14 | — | — | WO | claimed |
| US-7297554-B2 | Immunoassay system | MICRODIAGNOSTICS, INC. (US) | 2007-11-20 | — | — | US | claimed |
| US-20040087036-A1 | Comprises protein-binding membrane with antibodies bound thereto and absorbent pads with colloidal gold tracer adhered thereto | MICRODIAGNOSTICS, INC. | 2004-05-06 | — | — | US | claimed |
| US-20010026944-A1 | Immunoassay system | CHUNG ROY (US) | 2001-10-04 | — | — | US | claimed |
| EP-4713957-A1 | DOUBLE SINGLE-ION MONITORING MASS SPECTROMETRY | Roche Diagnostics GmbH (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4627350-A1 | DETECTION OF AN ANALYTE OF INTEREST BY A CHIP BASED NANOESI DETECTION SYSTEM | F. Hoffmann-La Roche AG (CH) | 2025-10-08 | — | — | EP | disclosed |
| EP-4623289-A1 | METHOD FOR DETERMINING AT LEAST ONE ANALYTE OF INTEREST | F. Hoffmann-La Roche AG (CH) | 2025-10-01 | — | — | EP | disclosed |
| US-5340748-A | Analyte-substitute reagent for use in specific binding assay methods, devices and kits | ABBOTT LABORATORIES (US) | 1994-08-23 | — | — | US | disclosed |
| EP-0566629-A1 | SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES USING A TIME-RESOLVED HETEROGENEOUS CHEMILUMINESCENCE ASSAY | ABBOTT LABORATORIES (US) | 1993-10-27 | — | — | EP | disclosed |
| WO-1992012255-A1 | SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES USING A TIME-RESOLVED HETEROGENEOUS CHEMILUMINESCENCE ASSAY | ABBOTT LABORATORIES (US) | 1992-07-23 | — | — | WO | disclosed |
| EP-0323605-A2 | Chromatographic binding assay devices and methods | ABBOTT LABORATORIES (US) | 1989-07-12 | — | — | EP | disclosed |